Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

mRNA Vaccinations vs COVID-19 Risk in Teens – Vaccinations are Safer

Case Western Reserve University researchers have demonstrated that the risk for myocarditis/pericarditis (heart inflammation) among male teens (12-17) diagnosed with COVID-19 is nearly 6 times higher than their combined risk following first and second doses of an mRNA COVID-19 vaccination.
The risk for myocarditis/pericarditis among girls (ages 12-17) is 21 times greater from COVID-19 than from vaccines.

Appropriate Technologies: The COVID-19-Era Heroes Yet to Come to “Center Stage”

The COVID-19 outbreaks in Thailand have seen an ever-increasing number of infections as new clusters are emerging. The faculty members of Sasin School of Management — Prof. Dr. Kua Wongboonsin, Asst. Prof. Dr. Piyachart Phiromswad, Assoc. Prof. Dr. Pattanaporn Chatjuthamard, Asst. Prof. Dr. Pattarake Sarajoti, and Asst. Prof. Dr. Sabin Srivannaboon, with financial support from the National Research Council of Thailand (NRCT), jointly present ways to reduce the spread of COVID-19 sustainably in a study to identify technologies that can instantly and appropriately help professionals who find social distancing difficult.

2 in 1 Face Mask Against Dust and Virus – Chula Health Innovation in the New Normal

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

COVID-19 shapes future of accessibility services at WVU

WVU’s Office of Accessibility Services saw a 900% increase in requests from deaf or hard of hearing students during the COVID-19 pandemic. Enlisting students on work study programs to do lecture transcriptions and closed captioning helped the University save nearly a quarter of a million dollars.

Mayo research provides insights into high-risk younger demographics for severe COVID-19

Using data from 9,859 COVID-19 infections, Mayo Clinic researchers have new insights into risk factors for younger populations, some of which differ significantly from their older counterparts. People younger than 45 had a greater than threefold increased risk of severe infection if they had cancer or heart disease, or blood, neurologic or endocrine disorders, the research found. These associations were weaker in older age groups. The study was published in Mayo Clinic Proceedings.

Novel autoantibody adds fuel to COVID-19 “firestorm” of inflammation, blood clots

Researchers at Michigan Medicine have discovered another functional autoantibody in COVID-19 patients that contributes to the disease’s development and the “firestorm” of blood clots and inflammation it induces. The autoantibody makes it harder for the body to degrade neutrophil extracellular traps, the toxic webs of DNA and proteins produced by overactive immune cells at heightened levels in COVID patients.

What if We Could Give Viruses a One-Two Punch?

Researchers at Stanford and Berkeley Lab’s Molecular Foundry have developed virus-killing molecules called peptoids. The technology could make possible an emerging category of antiviral drugs that could treat everything from herpes and COVID-19 to the common cold.

Study Supports Early Anticoagulant Treatment to Reduce Death in Moderately Ill COVID-19 Patients

Findings from an international multicenter trials showed that while a full dose of heparin didn’t statistically significantly lower incidence of the primary composite of death, mechanical ventilation or ICU admission compared with low-dose heparin, therapeutic heparin did reduce the odds of all-cause death by 78 percent.

COVID-19 SCAN: An Innovative, Proactive, Fast, Accurate, and Affordable Screening Kit by Chula Doctors

As the COVID-19 outbreaks continue to skyrocket with new clusters in numerous dark red areas in many provinces across the country, a research team led by Assoc. Prof. Dr. Sanchai Payungporn, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, has, therefore, accelerated the development of the innovative COVID-19 screening kits – “COVID-19 SCAN” that are convenient, fast, inexpensive, with efficiency, accuracy close to the Real-time PCR standards mandated by the Ministry of Public Health.

Scientists repurpose cancer and seizure medications to aid in the fight against COVID-19

Two teams of researchers using the Advanced Photon Source identified existing drugs — one used to treat cancer, the other an anti-seizure medication — that may work as treatments for COVID-19.

Ask an Expert: Have Drivers Gotten Worse Since COVID?

As the restrictions around COVID-19 are lifted, and more and more people hit the road to return to their work spaces and routines, you may have heard a familiar refrain: “People have forgotten how to drive.” Is it true? Are drivers worse now than they were before the coronavirus pandemic took over the world? The answer, according to Dwight A. Hennessy, department chair and professor of psychology at Buffalo State College, is probably not.

Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development

Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School (NJMS) and the Center for Theoretical Biological Physics (CTBP) at Rice University in Houston, Texas, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.

WVU professor: Personal desire, not shaming, should serve as motivator to arise from the unhealthy pits of COVID

George Kelley, a professor in West Virginia University’s School of Public Health, said he believes the key now is to push forward from the pandemic and into healthier lifestyles.

Study examines relationship between concern about COVID-19 and belief in science and faith

A new study from Arizona State University has shown that people in the U.S. relied more on science than religion to navigate the COVID-19 pandemic. The research team assessed faith and science mindsets – how people perceived faith in God or scientific information – as the pandemic progressed. People who had a stronger science mindset were more concerned about COVID-19 in the early months of the pandemic. Faith mindsets were not directly related to concern about the pandemic.

COVID-19 aggravates antibiotic misuse in India

Antibiotic sales soared during India’s first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to research led by Washington University School of Medicine in St. Louis. The excessive usage is especially concerning because antibiotic overuse increases the risk for drug-resistant infections — not just in India, but worldwide.

UT/TT Poll: Texans’ Views on Vaccines, Leadership, Legislation and the Future

The latest University of Texas/Texas Tribune poll showed significant differences along party lines on Texans’ attitudes about COVID-19 vaccines: 79% of Democrats report being vaccinated, compared with 47% of Republicans. And about a quarter of Texans (24%) say they are not planning on getting a vaccine.

SLAS Discovery’s July Special Edition “Drug Discovery Targeting COVID-19” Now Available

The July edition of SLAS Discovery is a Special Edition featuring the cover article, “Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry” by Lesley-Anne Pearson, Charlotte J. Green, Ph.D., De Lin, Ph.D., Alain-Pierre Petit, Ph.D., David W. Gray, Ph.D., Victoria H. Cowling, Ph.D., and Euan A. F. Fordyce, Ph.D., (Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, UK).

Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival

Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.

Institute of Human Virology Member Joins Scientific Advisory Committee of the Coalition for Epidemic Preparedness Innovations

The Coalition for Epidemic Preparedness Innovations (CEPI) announced that Alash’le Abimiku, PhD, Professor of Medicine of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, will join their Scientific Advisory Committee for three-years.

Butterfly Effect Can Double Travel of Virus-Laden Droplets

In Physics of Fluids, investigators from the University of Florida and Lebanese American University carried out detailed computer simulations to test a mathematical theory they developed previously. They found nearly identical exhalations could spread in different directions when miniscule initial variations are substantially amplified by turbulence. This is the so-called butterfly effect.

Reopening Anxiety? Here’s How to Overcome it According to University of Kentucky Experts

For nearly a year, we relied on masks to help prevent the spread of COVID-19. Now, many are removing the facial coverings, but that doesn’t mean it will be easy to shed the anxiety that accompanies a global pandemic. If you’re having difficulty coping with this added stress, psychology experts at the University of Kentucky say you’re not alone.